Increasing array of products to
ease the workflow is the major factor driving the ELISA
Analyzer Market growth over the forecast period. Enzyme Linked Immunosorbent
Assay (ELISA) is a biochemical assay, which use antibodies and an
enzyme-mediated color change to detect the presence of either antigen
(proteins, peptides, and hormones) or antibody in sample. Enzyme-linked
immunosorbent assay is used as diagnostic tool in medicine and analytical tool
in biomedical research. ELISA analyzer is an instrument used for detecting the
concentration and presence of analyte in the test sample. ELISA analyzer can be
used are a part of workflow were reagents and consumables are fed to carry out
ELISA and results are displayed on the screen attached to it, which is known as
automated ELISA analyzer.
Moreover, increasing prevalence
of infectious disease and drug development are also expected to fuel the ELISA
analyzer market growth over the forecast period. However, stringent regulatory
policies for product approval are expected to hinder the new product launches,
which in turn is restraining growth of the market.
ELISA Analyzer Market Dynamics
New product launches with
increased sophistication and value added testing environment to enhance
sensitivity coupled with compactness of product are expected to fuel growth of
the ELISA analyzer market over the forecast period. For instance, in 2017, Siemens
Healthineers, received CE approval for Atellica Solution, an automated
immunoassay and chemistry analyzers in Europe, the U.S., South America, and
Asia.
The product has comprehensive
menu of 170 assays, which include cardiac, thyroid, and reproductive tests.
Furthermore, the company has pipeline of about 50 more assays, which are
expected to be added to the present menu. In 2014, Sysmex Corporation launched
HISCL-800, a compact and automated immunoassay system used for the
immunochemistry testing. The product is claimed to be more compact as compared
to other products of same series.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1850
ELISA technique holds promising
results in diagnosis of health related problems. High prevalence of infectious
disease and cancer are propelling growth of the ELISA analyzer market. For
instance, according to World Health Organization (WHO), in 2016, an estimated
cases of malaria in 91 countries across the globe were around 216 million,
which increased by 5 million as compared to 2015. Moreover, funding and
initiatives to eradicate the disease burden are expected to increase the
adoption of diagnostic assay and advanced analyzer, in turn augment the ELISA
analyzer market growth.
Furthermore, increasing number of
drug discovery programs by pharmaceutical and biopharmaceutical companies are
propelling demands for improved and advanced instrument to ease with good
quality results in less time as a part of the workflow. According to
International Federation of Pharmaceutical Manufacturers & Associations, in
2015, new 56 medicines were launched, while currently more than 7,000 compounds
are at different stages of development worldwide. Such drug discovery
programmes prominently use ELISA in the clinical trial, in turn increasing
adoption of ELISA analyzer.
ELISA Analyzer Market - Regional
Analysis
Regional segmentation of the
market by Coherent Market Insights includes North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa. North America ELISA analyzer
market holds dominant position in global market, owing to increasing burden of
infectious disease, adoption of immunoassays in diagnosis, and presence of
local market players. For instance, according to National Ambulatory Medical
Care Survey, 2015, in the U.S. around 16.8 million visits were reported to
physician offices for infectious and parasitic diseases.
However, Asia Pacific ELISA analyzer market is expected to
witness rapid growth, owing to increasing demand from emerging economies such
as India, where large patient population demands for rapid and high-throughput
technology for test and detection of disease.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/elisa-analyzer-market-1850
ELISA Analyzer Market –
Competitive Analysis
Key players operating in the
ELISA analyzer market include Siemens Healthineers, Awareness Technology, Inc.,
Dynes Technologies, Inc., EUROIMMUN AG, Robimes, Gold Standard Diagnostics,
Corp., BioTek Instruments, Inc., and Berthold Technologies GmbH & Co. KG.
In 2016, Gold Standard
Diagnostics, Corp. and R-BioPharma AG collaborated on multiple technology and
marketing initiatives to leverages respective strength of both companies to
expand product offering and geographic sales coverage. In 2013, Gold Standard
Diagnostics, Corp. established distribution partnership for the ThunderBolt
automated immunoassay analyzer in 18 countries since its launch in 2012.
Key Development
In August 2019, PerkinElmer,
Inc., launched EUROIMMUN Aspergillus Antigen ELISA for detection of aspergillus
infections.
In 2017, Siemens Healthineers,
received CE mark for Atellica Solution, which is an automated immunoassay and
chemistry analyzer and are available in the U.S., Europe, South America, and
Asian markets.
In 2014, Sysmex Corporation
launched HISCL-800, a compact and automated immunoassay system used for the
immunochemistry testing.
In 2012, Dynex Technologies Inc.,
received china state food and drug administration (SFDA) approval for its DS2
automated enzyme-linked immunosorbent assay (ELISA) analyzer in China. This DS2
assay is considered to be an automated ELISA processing system for clinical
diagnostic assays.
In 2012, Gold Standard
Diagnostics, Corp. (GSD) launched fully automated ELISA platform thunderbolt
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1850
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment